Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CB-103 Plus NSAI In Luminal Advanced Breast Cancer: CAILA Study

NCT04714619 is registered in ClinicalTrials.gov with MedSIR as lead sponsor.

NCT NCT04714619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04714619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CB-103 Plus NSAI In Luminal Advanced Breast Cancer: CAILA Study
Lead sponsor
MedSIR
Phase
Phase 2
Overall status
Terminated
Start date
May 6, 2021
Completion date
April 26, 2022
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer